{"address1": "2101 Cottontail Lane", "city": "Somerset", "state": "NJ", "zip": "08873", "country": "United States", "phone": "732 317 5050", "website": "https://www.legendbiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate, ciltacabtagene autoleucel, or cilta-cel, is a chimeric antigen receptor (CAR-T) therapy for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma (NHL), acute lymphoblastic leukemia, gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. In addition, it develops allogeneic gamma delta CAR-T and allogeneic CAR-NK product candidates targeting B-cell maturation antigen (BCMA) for MM, which are in investigator-initiated Phase 1 clinical trials in China. The company has a collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of cilta-cel, and a license agreement with Novartis Pharma AG for the development, manufacture, and commercialization of CAR-T cell therapies targeting delta-like ligand protein 3. The company was founded in 2014 and is headquartered in Somerset, New Jersey. Legend Biotech Corporation operates as a subsidiary of Genscript Biotech Corporation.", "fullTimeEmployees": 2600, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ying  Huang Ph.D.", "age": 51, "title": "CEO & Director", "yearBorn": 1973, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jessie  Yeung M.B.A.", "age": 39, "title": "Interim CFO, Principal Financial Officer & Principal Accounting Officer", "yearBorn": 1985, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shu  Wu", "title": "Senior VP of Global Operations & GM of Legend China", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caroline LeCates Paul", "title": "Associate Director of Investor Relations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Pepin J.D.", "title": "General Counsel", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tim  Roberts", "title": "Global Compliance Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Elaine  Qian", "title": "VP & Global Head of Human Resources", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Guowei  Fang Ph.D.", "title": "President of Research & Development", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mythili  Koneru M.D., Ph.D.", "age": 45, "title": "Chief Medical Officer", "yearBorn": 1979, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Birk  Vanderweeen", "title": "Senior Vice President of Global Manufacturing & Supply", "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 33.93, "open": 34.34, "dayLow": 31.39, "dayHigh": 34.84, "regularMarketPreviousClose": 33.93, "regularMarketOpen": 34.34, "regularMarketDayLow": 31.39, "regularMarketDayHigh": 34.84, "payoutRatio": 0.0, "beta": 0.195, "forwardPE": -47.044777, "volume": 2196269, "regularMarketVolume": 2196269, "averageVolume": 1239878, "averageVolume10days": 1067550, "averageDailyVolume10Day": 1067550, "bid": 24.53, "ask": 40.24, "bidSize": 1, "askSize": 1, "marketCap": 5788616192, "fiftyTwoWeekLow": 30.17, "fiftyTwoWeekHigh": 60.87, "priceToSalesTrailing12Months": 9.228695, "fiftyDayAverage": 36.368, "twoHundredDayAverage": 43.576923, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 10805163008, "profitMargins": -0.28223, "floatShares": 161989576, "sharesOutstanding": 183648992, "sharesShort": 11387847, "sharesShortPriorMonth": 13344457, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.062, "heldPercentInsiders": 0.01332, "heldPercentInstitutions": 0.55513, "shortRatio": 8.71, "shortPercentOfFloat": 0.1191, "impliedSharesOutstanding": 182288000, "bookValue": 5.666, "priceToBook": 5.563008, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -177026000, "trailingEps": -0.96, "forwardEps": -0.67, "enterpriseToRevenue": 17.226, "enterpriseToEbitda": -36.716, "52WeekChange": -0.4409365, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 31.52, "targetHighPrice": 95.0, "targetLowPrice": 53.12, "targetMeanPrice": 78.01286, "targetMedianPrice": 80.0, "recommendationMean": 1.6087, "recommendationKey": "buy", "numberOfAnalystOpinions": 21, "totalCash": 1122683008, "totalCashPerShare": 3.057, "ebitda": -294288000, "totalDebt": 350603008, "quickRatio": 4.493, "currentRatio": 4.624, "totalRevenue": 627241024, "debtToEquity": 33.694, "revenuePerShare": 3.43, "returnOnAssets": -0.1084, "returnOnEquity": -0.15448, "grossProfits": -20884000, "freeCashflow": -38576876, "operatingCashflow": -144032992, "revenueGrowth": 1.347, "grossMargins": -0.033299997, "ebitdaMargins": -0.46918, "operatingMargins": -0.40187, "financialCurrency": "USD", "symbol": "LEGN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -7.102858, "regularMarketPrice": 31.52, "marketState": "PRE", "shortName": "Legend Biotech Corporation", "longName": "Legend Biotech Corporation", "fiftyDayAverageChange": -4.8479996, "fiftyDayAverageChangePercent": -0.13330398, "twoHundredDayAverageChange": -12.056923, "twoHundredDayAverageChangePercent": -0.27668136, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-06-05", "averageAnalystRating": "1.6 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1591363800000, "preMarketChange": 0.289999, "preMarketChangePercent": 0.9200476, "preMarketPrice": 31.81, "regularMarketChange": -2.4099998, "regularMarketDayRange": "31.39 - 34.84", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 1239878, "fiftyTwoWeekLowChange": 1.3500004, "fiftyTwoWeekLowChangePercent": 0.04474645, "fiftyTwoWeekRange": "30.17 - 60.87", "fiftyTwoWeekHighChange": -29.349998, "fiftyTwoWeekHighChangePercent": -0.4821751, "fiftyTwoWeekChangePercent": -44.09365, "earningsTimestamp": 1741690801, "earningsTimestampStart": 1747053000, "earningsTimestampEnd": 1747398600, "earningsCallTimestampStart": 1741694400, "earningsCallTimestampEnd": 1741694400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.96, "epsForward": -0.67, "epsCurrentYear": -0.76421, "priceEpsCurrentYear": -41.24521, "corporateActions": [], "preMarketTime": 1743595518, "regularMarketTime": 1743537601, "exchange": "NMS", "messageBoardId": "finmb_552805228", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "Legend Biotech", "trailingPegRatio": null}